0001140361-23-022950.txt : 20230504
0001140361-23-022950.hdr.sgml : 20230504
20230504161100
ACCESSION NUMBER: 0001140361-23-022950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230502
FILED AS OF DATE: 20230504
DATE AS OF CHANGE: 20230504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehta Piyush
CENTRAL INDEX KEY: 0001408238
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33626
FILM NUMBER: 23888802
MAIL ADDRESS:
STREET 1: 825 EIGHTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genpact LTD
CENTRAL INDEX KEY: 0001398659
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 980533350
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
BUSINESS PHONE: 4412952244
MAIL ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
4
1
form4.xml
X0407
4
2023-05-02
0001398659
Genpact LTD
G
0001408238
Mehta Piyush
C/O GENPACT LLC
521 FIFTH AVENUE, 14TH FLOOR
NEW YORK
NY
10175
true
Senior Vice President and CHRO
true
Common Shares
2023-05-02
4
M
0
32500
19.35
A
241540
D
Common Shares
2023-05-02
4
S
0
29929
43.7884
D
211611
D
Common Shares
2023-05-02
4
S
0
2571
44.5447
D
209040
D
Employee Stock Option (Right to Buy)
19.35
2023-05-02
4
M
0
32500
0
D
2023-05-30
Common Shares
32500
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.45 to $44.36. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.44 to $44.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.
/s/ Thomas D. Scholtes, as Attorney-in-fact for Piyush Mehta
2023-05-04